Treatment of steroid-resistant grade II to IV acute Gvhd by infusion of mesenchymal stromal cells expanded with platelet lysate: a phase I/II study
Liane te Boome(University Medical Center Utrecht), Jürgen Kuball(Utrecht University), Marloes Cuijpers(University Medical Center Utrecht), Gerwin Huls(University Medical Center Groningen), Eefke Petersen(University Medical Center Utrecht), Eric Spierings(University Medical Center Utrecht), Caroline A. Lindemans(University Medical Center Utrecht), Nico Wulffraat(Utrecht University), Lotte E. van der Wagen(University Medical Center Utrecht), Annoek E. C. Broers(Erasmus MC), Ineke Slaper‐Cortenbach(Maine Farmland Trust), Marc Bierings(University Medical Center Utrecht), C. Mansilla Puerta(University Medical Center Utrecht), Johannes W.G. Janssen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jaap Jan Boelens(Wilhelmina Children's Hospital), Henk Rozemuller(Utrecht University), C. Huisman(University of Amsterdam)
Unknown
April 1, 2013
Cited by 1
Related Papers
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
|Nature Genetics|2000|951
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
|Bone Marrow Transplantation|2016|396